Defense contractor Northop Grumman fell hard toward trend line support both before and after its earnings report last Friday, despite a solid beat of analyst expectations. The fall has occurred as analysts adjusted forward estimates of earnings and sales downward for the next two years. Despite the downward revisions, Northop Grumman remains a growth company, with...
Biogen today reported a huge earning beat, but disappointing guidance for the rest of the year. When you crunch the numbers, the midpoint of Biogen's guidance range for 2H 2020 came in slightly below Street consensus for both earnings and revenues. Biogen has a reasonable, but not great valuation, with forward PEG of 3.78 and forward PSG of 1.27. It's currently...
I saw a couple articles this morning suggesting that maybe TSM sold off today because forward guidance disappointed Street expectations. That's nonsense. Revenue guidance came in about 7% above expectations, and earnings guidance came in about 15% above Street expectations. This company's guidance crushed it . The stock sold off for one reason only: it is...